Nd:YAG & Alexandrite Long Pulse Laser Therapy Instrument (LPDuo)
Keyue (Hangzhou) Medical Information Technology Co., Ltd. · Decision date Oct 13, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-13 for K261572, a traditional 510(k) submitted by Keyue (Hangzhou) Medical Information Technology Co., Ltd. for the Nd:YAG & Alexandrite Long Pulse Laser Therapy Instrument (LPDuo). The device is listed under the classification name Powered Laser Surgical Instrument, regulation 878.4810, product code GEX, with the review panel and medical specialty recorded as General & Plastic Surgery. The application was received 05/12/2026.
SESE in a 510(k) means the applicant demonstrated substantial equivalence to a legally marketed predicate; it is a clearance, not a PMA approval. The record shows no third-party review, no combination product designation and no authorized predetermined change control plan. The public summary does not state the predicate device, the specific indications cleared, or any technical differences from the predicate, so the scope of the clearance beyond the device name and classification cannot be determined from this record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 13, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261572
- Regulatory pathway
- 510(k) premarket notification
- Product code
- GEX
- Decision code
- SESE
- Decision date
- Oct 13, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Laser Surgical Instrument.
- Product code
- GEX
- FDA device class
- 2
FDA decision timeline
K261572 received
Application receipt date recorded by FDA.
K261572 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Single Use Optical FiberK262886 | Quanta System Spa | 510(k) clearance | Nov 5, 2026 | FDA |
| Borze, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Risu Medical Technology Co., Ltd. | 510(k) clearance | Oct 27, 2026 | FDA | |
| Sanhe PERFECTLASER Technology Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Beijing Sea Heart International Science and Technologyco.Ltd | 510(k) clearance | Oct 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Keyue (Hangzhou) Medical Information Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Hangzhou
Sources and methodology
- Original FDA record: K261572
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


